Filing Details

Accession Number:
0000899243-21-040454
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-18 16:15:26
Reporting Period:
2021-10-15
Accepted Time:
2021-10-18 16:15:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1789972 Cullinan Oncology Inc. CGEM Biological Products, (No Disgnostic Substances) (2836) 813867811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1838671 Jeffrey Trigilio C/O Cullinan Oncology, Inc.
One Main Street, Suite 520
Cambridge MA 02142
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-15 8,000 $4.30 10,250 No 4 M Direct
Common Stock Disposition 2021-10-15 8,000 $25.00 2,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-10-15 8,000 $0.00 8,000 $4.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
229,891 2030-10-28 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 30, 2021.
  2. 25% of the shares vested on September 8, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.